Drug recall · January 23, 2013
Perindopril Erbumine Tablets recall
Why: Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.
- Lots / codes
Lot #160017A, Exp 04/2013.
- Quantity
- 3,553 bottles
- Company
- Boehringer Ingelheim Roxane Inc, Columbus, OH
- Distribution
- Nationwide
- Initiated
- December 12, 2012 · Voluntary: Firm initiated
- Classified
- January 16, 2013
- Reported
- January 23, 2013
- Ended
- June 16, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Perindopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.